NasdaqGS - Delayed Quote USD
CeriBell, Inc. (CBLL)
17.89
+0.39
+(2.23%)
At close: June 6 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
71,535
65,444
45,225
25,922
Cost of Revenue
9,120
8,694
7,062
4,430
Gross Profit
62,415
56,750
38,163
21,492
Operating Expense
107,878
96,459
68,204
57,513
Operating Income
-45,463
-39,709
-30,041
-36,021
Net Non Operating Interest Income Expense
-2,028
-1,992
-2,098
-1,603
Other Income Expense
2,780
1,246
2,686
462
Pretax Income
-44,711
-40,455
-29,453
-37,162
Tax Provision
0
0
11
2
Net Income Common Stockholders
-44,711
-40,455
-29,464
-37,164
Diluted NI Available to Com Stockholders
-44,711
-40,455
-29,464
-37,164
Basic EPS
-1.25
-3.39
-1.26
-1.59
Diluted EPS
-1.25
-3.39
-1.26
-1.59
Basic Average Shares
35,897.06
11,949.97
23,324.24
23,324.24
Diluted Average Shares
35,897.06
11,949.97
23,324.24
23,324.24
Total Operating Income as Reported
-45,463
-39,709
-30,041
-36,021
Total Expenses
116,998
105,153
75,266
61,943
Net Income from Continuing & Discontinued Operation
-44,711
-40,455
-29,464
-37,164
Normalized Income
-43,217
-38,959
-29,512
-36,989
Interest Expense
2,028
1,992
2,098
1,603
Net Interest Income
-2,028
-1,992
-2,098
-1,603
EBIT
-42,683
-38,463
-27,355
-35,559
EBITDA
-41,464
-37,322
-26,508
-35,062
Reconciled Cost of Revenue
9,120
8,694
7,062
4,430
Reconciled Depreciation
1,219
1,141
847
497
Net Income from Continuing Operation Net Minority Interest
-44,711
-40,455
-29,464
-37,164
Total Unusual Items Excluding Goodwill
-1,494
-1,496
48
-175
Total Unusual Items
-1,494
-1,496
48
-175
Normalized EBITDA
-39,970
-35,826
-26,556
-34,887
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 10/11/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BBNX Beta Bionics, Inc.
19.08
-2.40%
NPCE NeuroPace, Inc.
13.15
-0.98%
KIDS OrthoPediatrics Corp.
21.19
+1.58%
LUNG Pulmonx Corporation
3.1700
+6.73%
OM Outset Medical, Inc.
20.93
+4.34%
NMTC NeuroOne Medical Technologies Corporation
0.5817
-1.24%
AXGN Axogen, Inc.
10.92
+1.11%
MYO Myomo, Inc.
2.9800
-0.33%
INSP Inspire Medical Systems, Inc.
136.02
+0.11%
CVRX CVRx, Inc.
6.56
+1.55%